vs
Side-by-side financial comparison of Allstate (ALL) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Allstate is the larger business by last-quarter revenue ($922.0M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). Allstate runs the higher net margin — 266.6% vs 6.8%, a 259.8% gap on every dollar of revenue. On growth, Allstate posted the faster year-over-year revenue change (7.2% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ALL vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $493.8M |
| Net Profit | $2.5B | $33.7M |
| Gross Margin | — | — |
| Operating Margin | -1400.3% | 9.9% |
| Net Margin | 266.6% | 6.8% |
| Revenue YoY | 7.2% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $9.25 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $493.8M | ||
| Q3 25 | $17.3B | $492.9M | ||
| Q2 25 | $16.6B | $468.8M | ||
| Q1 25 | $16.5B | $458.4M | ||
| Q4 24 | $16.5B | $502.4M | ||
| Q3 24 | $16.6B | $511.2M | ||
| Q2 24 | $15.7B | $504.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $33.7M | ||
| Q3 25 | $3.7B | $71.7M | ||
| Q2 25 | $2.1B | $39.3M | ||
| Q1 25 | $595.0M | $20.7M | ||
| Q4 24 | $1.9B | $30.5M | ||
| Q3 24 | $1.2B | $19.4M | ||
| Q2 24 | $331.0M | $-153.0M |
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% |
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | 6.8% | ||
| Q3 25 | 21.7% | 14.5% | ||
| Q2 25 | 12.7% | 8.4% | ||
| Q1 25 | 3.6% | 4.5% | ||
| Q4 24 | 11.7% | 6.1% | ||
| Q3 24 | 7.2% | 3.8% | ||
| Q2 24 | 2.1% | -30.3% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $0.40 | ||
| Q3 25 | $13.95 | $0.84 | ||
| Q2 25 | $7.76 | $0.46 | ||
| Q1 25 | $2.11 | $0.24 | ||
| Q4 24 | $7.07 | $0.37 | ||
| Q3 24 | $4.33 | $0.23 | ||
| Q2 24 | $1.13 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $31.6B | $865.9M |
| Total Assets | $124.0B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $375.2M | ||
| Q3 25 | $8.7B | $340.1M | ||
| Q2 25 | $9.6B | $224.7M | ||
| Q1 25 | $6.5B | $99.0M | ||
| Q4 24 | $4.5B | $229.9M | ||
| Q3 24 | $7.0B | $103.8M | ||
| Q2 24 | $5.3B | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $570.5M | ||
| Q3 25 | $8.1B | $577.2M | ||
| Q2 25 | $8.1B | $583.9M | ||
| Q1 25 | $8.1B | $590.5M | ||
| Q4 24 | $8.1B | $597.1M | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.1B | — |
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $865.9M | ||
| Q3 25 | $27.5B | $890.7M | ||
| Q2 25 | $24.0B | $833.8M | ||
| Q1 25 | $22.1B | $789.2M | ||
| Q4 24 | $21.4B | $764.9M | ||
| Q3 24 | $20.9B | $732.5M | ||
| Q2 24 | $18.6B | $706.5M |
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $2.2B | ||
| Q3 25 | $120.4B | $2.2B | ||
| Q2 25 | $115.9B | $2.1B | ||
| Q1 25 | $115.2B | $2.0B | ||
| Q4 24 | $111.6B | $2.2B | ||
| Q3 24 | $113.7B | $2.1B | ||
| Q2 24 | $108.4B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | 0.66× | ||
| Q3 25 | 0.29× | 0.65× | ||
| Q2 25 | 0.34× | 0.70× | ||
| Q1 25 | 0.37× | 0.75× | ||
| Q4 24 | 0.38× | 0.78× | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $114.1M | ||
| Q3 25 | $3.3B | $137.3M | ||
| Q2 25 | $1.9B | $137.2M | ||
| Q1 25 | $2.0B | $-117.5M | ||
| Q4 24 | $1.7B | $133.0M | ||
| Q3 24 | $3.2B | $91.8M | ||
| Q2 24 | $2.4B | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $2.3B | — |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | — | ||
| Q3 25 | 18.8% | — | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 18.9% | — | ||
| Q2 24 | 14.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | 3.39× | ||
| Q3 25 | 0.88× | 1.91× | ||
| Q2 25 | 0.89× | 3.49× | ||
| Q1 25 | 3.30× | -5.66× | ||
| Q4 24 | 0.88× | 4.36× | ||
| Q3 24 | 2.69× | 4.72× | ||
| Q2 24 | 7.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALL
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
